disadvantage of the company. >> one other question about -- we get closer to seeing emergency authorization for pfizer for kids 5 to 11. i know overseas, some countries have approved only one dose. there are quite a few doctors that have brought up the idea that could two dose cause an increased risk of heart issues for younger folks during development stages? where are you on this issue? >> the myocarditis does increase in frequency. it's a rare event in the adolescent compared to the young adults. the concern is that as you get to younger myocarditis will increase. we have no evidence of that. the data packet submitted to the fda has 3,000 kids in it, which would be not enough to assess that myocarditis safety signal.